Boston Scientific
(NYSE: BSX)
today announced two new appointments to its board of directors.
Marlborough, Massachusetts-based Boston Scientific elected Dr. Jessica Mega and Susan Morano to the board. Both appointments go into effect immediately.
Mega co-founded Verily Life Sciences, the Google/Alphabet subsidiary focused on life sciences and healthcare. She served as chief medical and scientific officer from 2015 to January 2023.
Before joining Verily, Mega served as a cardiologist at Brigham & Women’s Hospital from 2008 to 2015. She also held roles as a faculty member at Harvard Medical School and with the TIMI Study Group. Mega also currently serves as a director on the board at Danaher.
Morano served as VP of business development and strategic operations at Johnson & Johnson MedTech from 2020 to February 2023. Before that, the new Boston Scientific board member held the role of VP of business development at J&J Medical Devices.
Other roles at Johnson & Johnson included a number of positions within six operating companies, primarily in finance and business development functions.
“We are pleased to expand our board of directors with two highly qualified executives from different sectors of the healthcare industry,” said Mike Mahoney, CEO and chair of the board, Boston Scientific. “Jessica and Susan are accomplished leaders passionate about advancing patient care and experienced in bringing innovative technologies to market, and we look forward to their contributions as board members as Boston Scientific continues to grow and meet our stakeholder commitments.”
